Inventor
SUGIMOTO TAKAHIRO
JP46 patents
⚠️ This page may combine multiple inventors who share the name “SUGIMOTO TAKAHIRO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
32 patentsUS10584097B2Mar 10, 2020
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO14 citations94
US10428023B2Oct 1, 2019
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO22 citations94
US9518042B2Dec 13, 2016
Nitrogen-containing heterocyclic compound
TAKEDA PHARMACEUTICALS CO8 citations92
US9499516B2Nov 22, 2016
Nitrogen-containing heterocyclic compound
TAKEDA PHARMACEUTICALS CO8 citations92
US10548899B2Feb 4, 2020
Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity
TAKEDA PHARMACEUTICALS CO7 citations84
US10457670B2Oct 29, 2019
Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimers disease
TAKEDA PHARMACEUTICALS CO2 citations84
US10428056B2Oct 1, 2019
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations84
US10323027B2Jun 18, 2019
2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
TAKEDA PHARMACEUTICALS CO4 citations84
US10087150B2Oct 2, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO5 citations84
US9878989B2Jan 30, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO7 citations84
US9868725B2Jan 16, 2018
Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's disease
TAKEDA PHARMACEUTICALS CO5 citations84
US9789083B2Oct 17, 2017
Nitrogen-containing heterocyclic compound
TAKEDA PHARMACEUTICALS CO2 citations84
US9789084B2Oct 17, 2017
Nitrogen-containing heterocyclic compound
TAKEDA PHARMACEUTICALS CO2 citations84
US9775827B2Oct 3, 2017
Nitrogen-containing heterocyclic compound
TAKEDA PHARMACEUTICALS CO2 citations84
US9675597B2Jun 13, 2017
Nitrogen-containing heterocyclic compound
TAKEDA PHARMACEUTICALS CO2 citations84
US9662316B2May 30, 2017
Nitrogen-containing heterocyclic compound
TAKEDA PHARMACEUTICALS CO2 citations84
US9655881B2May 23, 2017
Nitrogen-containing heterocyclic compound
TAKEDA PHARMACEUTICALS CO2 citations84
US9403802B2Aug 2, 2016
Heterocyclic compound and use therefor
TAKEDA PHARMACEUTICALS CO12 citations84
US11440883B2Sep 13, 2022
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO3 citations73
US10899752B2Jan 26, 2021
2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
TAKEDA PHARMACEUTICALS CO1 citations73
US10208046B2Feb 19, 2019
Nitrogen-containing heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations73
US9777005B2Oct 3, 2017
Bicyclic heterocyclic compound containing a substituted pyrrole ring
TAKEDA PHARMACEUTICALS CO5 citations73
US11655241B2May 23, 2023
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO2 citations72
US11319286B2May 3, 2022
Heterocyclic compound and application thereof
TAKEDA PHARMACEUTICALS CO4 citations72
US10865200B2Dec 15, 2020
Nitrogen-containing heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations63
US12421188B2Sep 23, 2025
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations62
US12415782B2Sep 16, 2025
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations62
US12404237B2Sep 2, 2025
Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives
TAKEDA PHARMACEUTICALS CO0 citations62
US12358879B2Jul 15, 2025
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations61
US12091410B2Sep 17, 2024
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations50
US12071434B2Aug 27, 2024
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations50
US10131653B2Nov 20, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations50
ASGENT INC
3 patentsUS7260830B2Aug 21, 2007
Method and apparatus for establishing a security policy, and method and apparatus for supporting establishment of security policy
ASGENT INC357 citations98
US7337105B2Feb 26, 2008
Electronic equipment setting information creating method and apparatus, and security policy creating method and associated apparatus
ASGENT INC14 citations83
US7823206B2Oct 26, 2010
Method and apparatus for establishing a security policy, and method and apparatus of supporting establishment of security policy
ASGENT INC6 citations73